Strategic Acquisition Appears to have been involved in a notable acquisition by Prescient Medicine in 2017, suggesting potential interest in integrated pharmacogenetics and predictive health platforms. This history implies openness to partnerships or consolidation with larger players for expanded distribution and scale.

Pharmacogenetics Focus Specializes in pharmacogenetics testing and molecular diagnostics for personalized medicine, indicating a clear fit for labs, clinics, and pharma partners seeking targeted companion diagnostics and precision medicine solutions.

SMB Scale Small to mid-size operation (11-50 employees) with a revenue range of $1M-$10M, suggesting a nimble partner open to scalable collaborations, white-label services, and flexible contracting models that complement larger suppliers.

Lab Services Portfolio Offers a full range of pharmacogenetic and anatomic pathology testing plus research services for drug and device developers, presenting multiple cross-sell opportunities across clinical, translational research, and regulatory testing verticals.

Digital & Analytics Uses a modern digital stack and analytics tools (WordPress, Google Analytics, Search Console, etc.), indicating potential for digital marketing partnerships, data-driven studies, and enhanced online education or outreach collaborations to drive referrals and awareness.